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Abstract
Background: The serum biomarker N-terminal proB-
type natriuretic peptide (NT-proBNP), a cleaved frag-
ment of the brain natriuretic peptide (BNP) precursor
(amino acids 1–76), is accepted as a standard marker
for evaluating and monitoring cardiac injury charac-
terized by myocardial wall stress. Strenuous exercise
may generate transitory ischemia, myocardial stress
and diastolic left ventricular dysfunction, possibly
inducing increased concentrations of NT-proBNP. A
purported caveat to prolonged strenuous exercise is
based on evidence for biochemical and structural
signs of heart dysfunction in recreational athletes
after continuous exertion.
Methods: We compared NT-proBNP levels in three
groups of physically fit subjects: top-level rugby
players, professional soccer players and healthy con-
trols. NT-proBNP concentrations were measured at
rest and after an intensive training session followed
by two different recovery strategies (passive or
active).
Results: A comparison of the three samples showed
that NT-proBNP concentrations in the rugby players
were lower than those in controls at rest and were
similar to those in professional soccer players. Ele-
vated post-training NT-proBNP levels were unaffected
by the type of recovery. The relatively high NT-pro-
BNP levels after active recovery when psychophysical
stress is higher, because of cycling and cold water
immersion, suggest that not only endurance exercise,
but also strenuous, stressful short exercise can induce
an increase in NT-proBNP concentrations.
Conclusions: In this sample of professional athletes,
NT-proBNP was low at rest, and the increase after
physical exercise was physiological.
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Introduction
The serum biomarker N-terminal proB-type natriuretic
peptide (NT-proBNP), the cleaved fragment of the pre-
cursor of brain natriuretic peptide (amino acids 1–76),
is accepted as a parameter useful for evaluating and
monitoring cardiac injury characterized by myocardial
wall stress in association with additional instrumental
and biochemical parameters. Strenuous exercise may
generate transitory ischemia, myocardial stress and
diastolic left ventricular dysfunction, often inducing
an increase in biomarker concentrations commonly
measured to determine heart anomalies (1).
Cardiac damage during marathon running has been
described in 60 recreational athletes who participated
in the 2004 and 2005 Boston Marathon: 60% of rec-
reational runners showed increased troponin T after
the race and NT-proBNP concentration approximately
doubled. Left ventricular size and ejection fraction did
not change, but reduced left ventricular compliance
was echocardiographically demonstrated. Changes in
biochemical signs of cardiac damage were greater in
subjects who had a low training workload (2). These
data suggest that appropriate training is fundamental
for reducing and/or averting possible cardiac injury.
A caveat to prolonged, strenuous physical exercise is
the potential cardiovascular damage it may cause (1).
Increased NT-proBNP levels after physical exercise
typically described in endurance athletes (3, 4) were
not found to differ between endurance male athletes
with athlete’s heart and healthy untrained control
subjects with a normal sized heart (5). Moreover,
NT-proBNP concentrations in a group of professional
cyclists at rest were lower than those of sedentary
controls (6). The actual meaning of elevated
NT-proBNP in athletes clearly needs to be defined
more accurately.
We compared the changes in NT-proBNP levels
in professional athletes at rest vs. non-athletes and
during strenuous training sessions followed by two
different methods of recovery that could have affect-
ed psychophysical stress and biochemical
parameters.
Materials and methods
The study was conducted on 30 professional male rugby
players of the Italian National Team during a July training
camp before the start of the competitive season. Informed
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Table 1 Median (and 95% confidence interval) NT-proBNP levels (pg/mL) in rugby players before and after training and
recovery.
Type of recovery Before training After training After recovery p-Value, F-ratio
Passive (rest) 27.1 (17.8–41.3) 47.7 (28.7–71.8) 48.8 (30.6–75.0) -0.01, 5.1
Cold water immersion 30.2 (14.1–46.8) 57.4 (28.8–95.2) 64.3 (26.8–85.1) -0.001, 10.9
followed by active recovery
Active recovery followed 38.6 (18.6–75.9) 78.1 (35.3–150.0) 88.6 (33.7–144.0) -0.05, 5.1
by cold water immersion
consent was obtained from all participants. The anthropo-
metrical characteristics were body mass index (BMI,
27.5"1.0 kg/m2) and age (26"2 years) (mean"standard
deviation). The athletes were examined by the team sports
physicians, sports cardiologists and by means of laboratory
tests (7).
Blood samples were drawn before and after training on
the same day on K2 EDTA Vacutainer (Becton Dickinson,
Rutherford, NJ, USA) tubes and were immediately centri-
fuged at 2000 rpm (1500=g), the obtained plasma and sera
were stored at –208C until analysis. The samples were drawn
at 08:00 h (at rest) and at 17:00 h (after training session).
The analyses were performed in a single batch 2 weeks
after the collection. The same assay was used for all the
samples. The circulating volume was monitored by means
of hemoglobin and hematocrit values measured on a Coulter
750 (Coulter, Hialeah, FL, USA).
NT-proBNP, Naq, Kq and Mg2q were measured using a
Vitros system (Johnson & Johnson, Raritan, NJ, USA); the
instrument precision (coefficient of variance) was -5%.
The field session started with speed agility warm-ups
followed by step work with ballistic stretching (15 min), on
field practice (90 min) with play starts, general movement
sequences (up to 8 sequences), and then intense accelera-
tions. Taken together, it was a mixed fuel energy session,
with cardio-dominance and lactacid peaks, divided into
phases of 10-min workouts and 3-min rest periods between
two consecutive phases during which the players had con-
tacts and various play situations. The sample was then divid-
ed into three groups of 10 athletes, each randomly assigned
to passive recovery (rest) or active recovery (cycling at
180 W) for 10 min followed by cold water immersion (58C)
of the legs for 10 min or cold water immersion of the legs
for 10 min followed by active recovery. Athletes whose
NT-proBNP values at rest were not immediately available
were distributed randomly into one of the three groups.
A second sample of professional athletes were 44 soccer
players from the second (ns36) and third (ns12) divisions
of the Italian National Championship league (mean age
23"4 years, BMI 22"0.8 kg/m2). Blood samples were drawn
at rest in July before the start of the training and competitive
season.
The control group (ns12) was composed of technical and
medical staff members of the rugby team, eight of which
were former athletes (mean age 38"5 years), who were
physically fit, exercised moderately at least 1 h daily and fol-
lowed a diet and lifestyle similar to those of the athletes.
The level of statistical significance was set at 0.05. Analysis
of variance (ANOVA) was used to evaluate data obtained
during the training session. Normal distribution was evalu-
ated with the D’Agostino-Pearson test. Statistical analysis
was carried out using MedCalc software (Mariakerke,
Belgium).
Results
The median NT-proBNP level was 29.1 pg/mL (range
15.1–70.1 pg/mL) in the rugby players, 32.4 pg/mL
(range 11.3–91.8 pg/mL) in the soccer players
(p)0.05) and 51.9 pg/mL (range 30.1–77.3 pg/mL) in
controls (p-0.001). The distribution of the values was
not normal.
The NT-proBNP values in the rugby players before
and after the training session followed by passive and
active recovery are presented in Table 1. The training
session significantly increased NT-proBNP concentra-
tions across all three groups, regardless of recovery
method. The median value after training was 57.1
pg/mL (range 27.2–143.8 pg/mL) and 61.7 pg/mL
(range 29.2–176.4 pg/mL) after recovery. Changes in
Naq, Kq and Mg2q concentrations after training and
recovery were not significant, as well as hemoglobin
and hematocrit values: the athletes were euvolemic
during the observation period.
Discussion
Biochemical markers are routinely used for diagnos-
ing and monitoring heart diseases when necrosis or
damage or wall stress is present. NT-proBNP is usu-
ally measured to evaluate wall stress and heart fail-
ure. Biochemical cardiac markers can show increased
concentrations after physical exercise, especially after
strenuous exertion (2, 4, 8). Increases in NT-proBNP
could be interpreted as transitory heart damage
linked to possible harmful consequences for profes-
sional or recreational athletes and to exercise inten-
sity and duration (1). The implications for elevated
concentrations are controversial. A study on recrea-
tional marathon runners showed marked changes
between the pre-race median of 106 pg/mL and the
post-race median of 182 pg/mL (2). Notably, the con-
centrations in these marathon runners were higher at
rest than the values observed in healthy subjects
recruited from the general population (9) and in other
marathon runners (mean of 44 pg/mL before the race)
(8). One explanation for the elevated pre-race median
value is that the recreational athletes probably per-
formed physical exercise before blood drawing,
because the accurate instrumental examinations
excluded heart diseases. By contrast, we observed
low NT-proBNP levels in professional athletes at rest.
Rugby is a prevalently aerobic sport characterized by
strenuous effort during competitions and training. In
our sample, the NT-proBNP concentrations were low-
er than those observed in physically active non-ath-
letes. Our data are in line with the results from a study
on 20 endurance athletes (10 triathletes, 5 cyclists, 5
marathon runners), where a median of 24.7 pg/mL in
the athletes vs. 28.9 pg/mL in controls was found (5).
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Lippi et al. (6) also found lower mean levels of NT-
proBNP in 50 professional cyclists compared with 35
sedentary subjects (23.6 pg/mL vs. 36.3 pg/mL).
In professional athletes NT-proBNP values at rest
are low, within the physiological reference interval,
and even lower than those observed in non-athletes.
The elevation of NT-proBNP levels should be )95th
percentile of the general population. A concentration
of 125 pg/mL is usually considered as a threshold for
pathological values. Thus, most elevated levels dur-
ing physical exercise could be considered into the
variability of the reference range.
Athlete’s heart is not characterized by biochemical
signs of wall stress. In fact, the absence of a correla-
tion between left ventricular mass and BNP concen-
tration at rest has been reported (5). As strenuous
physical exercise induces an increase in NT-proBNP
concentrations in professional athletes, it could be
argued that appropriately trained athletes have a
lower production of the peptide at rest and that the
exercise-induced increase is insufficient to reach
abnormal limits. In our sample, we found that differ-
ent training recovery programs did not substantially
affect post-training NT-proBNP concentrations. The
relatively high levels of NT-proBNP after active recov-
ery, when psychophysical stress is higher because of
cycling and cold water immersion, suggest that not
only endurance exercise, but also strenuous, stressful
and short exercise can induce an increase in
NT-proBNP. It should be noted that NT-proBNP has
large within-day biological variability in heart failure
patients (10): modifications of their concentration
could also be induced by circadian changes, although
the increase due to heavy effort can easily overcome
the biological variability.
Changes in NT-proBNP after passive or active
recovery differed from those of creatine kinase
released from skeletal muscle (11), but are similar to
those reported by Scharhag et al. (3) in mountain bik-
ers and marathon runners after 1 and 3 h of exercise,
respectively. Increased NT-proBNP is also linked to
the different lifespan of the molecule in comparison
with intact BNP, which does not increase after endur-
ance sports performances (12).
A distinction needs to be made between physiolog-
ical increases in NT-proBNP during and after exercise
and abnormal increases due to heart damage. Our
data support the hypothesis that rather than signal-
ling heart injury, the growth-regulating properties of
BNP in exercise regulate myocardial adaptation in
healthy athletes (3) and are physiologically induced
by the release of systemic inflammatory cytokines
(13). In efforts to solve this dilemma, the athlete could
be an efficient and reliable model for studying
NT-proBNP changes during exercise-induced myocar-
dial stress.
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